Trastuzumab Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer
Jim Weiss: Make It Happen
Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
HUTCHMED Reports Positive Phase 3 SANOVO Results for Savolitinib Plus Osimertinib in EGFR-Mutated NSCLC
Pashtoon Kasi: Lessons from the NEST Phase 2 Trial in Colon Cancer
The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
By Women, for Women: The Untold Stories at the Roots of Oncology
An Appeal for Solidarity, Compassion, and Support for Nepal’s Ongoing Rescue and Recovery Efforts
